DISCLOSURE ESPACE GAIA, FIRST DCR IN PARIS SINCE OCTOBER /06/2017

Similar documents
First results collected by Argos, DCR in Strasbourg opened in november 2016

ARISTOTLE HCV-HIV: A fast-track intervention to seek-test-link-treat PWID in Athens, Greece

ANNUAL PROJECT PROGRESS REPORT FOR 2008 (draft)

Feedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014

Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario

Signs of success latest national NESI data?

Regional Program Harm Reduction Works Fund It! Baseline assessment. Country: Georgia. Preliminary analysis. 10 October 2014

COUNTRY TABLE. MONTENEGRO.

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015

Integrated harm reduction services for drug users and homeless people. Katrin Schiffer

Catalyst for Change. Viral Hepatitis Control Program Country Model Ukraine. Zahedul Islam

Drug Consumption Rooms Worldwide

Medical Director. and in prison settings in Romania. Ministry of Justice National Administration of Penitentiaries L IŢ

Hepatitis C Elimination Program Georgia

Models of care for management of HCV among PWID. Philip Bruggmann Switzerland

Part 1: Introduction & Overview

Strategies of drug users to avoid infection with hepatitis C

OF THE REPUBLIC OF ARMENIA DECREE. 316 of 1 April 2002 Yerevan

NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen

Models of good practice in drug treatment in Europe. Project group

COUNTRY REPORT: EPIDEMIOLOGICAL SITUATIONS AND PROJECT ACTIVITIES

The impact of economic recession on drug users and drug treatment

United Nations Office on Drugs and Crime (UNODC)

HCV Action and Bristol & Severn ODN workshop, 14 th September 2017: Summary report

The role of UNODC in working law enforcement agencies to promote harm reduction. IHRC, Bangkok, 23 April 2009

Integrated Drug Policy in Portugal

HEPATITIS MOBILE TEAM

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

PREVENTION OF HCV IN PEOPLE WHO INJECT DRUGS

Section 7: Providing HCV testing and treatment to people who inject drugs

What You Need to Know about Safer Inhalation. Ontario Harm Reduction Conference FEBRUARY 2013

Public drug policies Catalonia

Becoming a harm reduction distribution agency in Toronto - information session

7th International Symposium on Hepatitis Care in Substance Users

Toronto Declaration: Strategies to control and eliminate viral hepatitis globally. A call for coordinated action

Toronto Declaration 2014: Global Strategies to control and eliminate viral hepatitis globally. A call for coordinated action

Prevention and control of Hepatitis B and C among vulnerable groups Estonia: People who use drugs

ACCESS AND IMPLEMENTATION OF IFN-FREE THERAPY IN PEOPLE WHO INJECT DRUGS : WHERE TO FROM HERE FOR LOW AND MIDDLE INCOME COUNTRIES

Integration of collaborative TB/HIV activities with harm reduction services

Smoking cessation interventions and services

Prevention and control of viral hepatitis: Role and impact of liver patient groups in Europe. The Netherlands National hepatitis Centre

Overview of Evidence for Sterile Syringe Access. Hilary McQuie Western Director Harm Reduction Coalition

Hepatitis C Strategy. About us. What is hepatitis C?

Epidemiological Background (Ukraine)

Housing Ready vs. Housing First. Mission: 2/21/17

Syringe Exchange Programs: Getting Started

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

CROATIA. Venija Cerovecki, MD, GP. University of Zagreb School of Medicine Department for Family Medicine

Harm Reduction in Nigeria

Presenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin

CURING HEPATITIS C IN GENERAL PRACTICE: THE FIRST 60 DAYS

Ministry of Health and Long-Term Care Overdose Prevention Sites: User Guide for Applicants

HARM REDUCTION IN ASIA. Adeeba Kamarulzaman University of Malaya, Kuala Lumpur

Public Health Association of British Columbia

2012 Assessment of St. Lucie County s Social, Health, and Public Safety Services

Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs

HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres

Wagida A. Anwar, M.D. Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain Shams University, Egypt.

CABINET PROCURING A SUBSTANCE MISUSE & COMMUNITY TREATMENT SERVICE IN RUTLAND

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

SAN FRANCISCO SAFE INJECTION SERVICES TASK FORCE

The italian interactive system for addiction data management

Treatment and Harm Reduction in Prisons. Republic of Moldova

Pragmatic and Creative Responses to the Opioid Crisis in Connecticut

New London CARES Coordinated Access, Resources, Engagement and Support

1.0 BACKGROUND / PROJECT DESCRIPTION

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

STRATEGIC PLAN AGAINST VIRAL HEPATITIS IN SENEGAL ( ) POLICY BRIEF

THE GOVERNMENT DECREES: Chapter I GENERAL PROVISIONS

About Project Sunrise

Analysis on Annual Reports 2011 Victim Support Europe Members

Overall aim Improving the access to and the quality of health and social services for marginalised people

Review on HIV & Associated Infections in Latvia

SUMMARY OF INTERIM REPORT

ORGANIZATION OF AMERICAN STATES

Tajikistan National Report. Summary HARM REDUCTION WORKS FUND IT! Arguments for strategic investment. Summary of National Report: Tajikistan

Oregon s Syndemic: Substance Use, Overdose, STIs, associated conditions and IDU-related infections. Framework and Response Models

TANZANIA NATIONAL STRATEGIC PLAN FOR CONTROL OF VIRAL HEPATITIS

Key Ministry & Government Initiatives

Building a New Approach to Health Care Services for Hard to Reach Clients

Physical Activity Prescription in France

[harm-reduction] ROMANIA NEEDS SUPPORT - national drug agency to be moved under police

Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs

Technical Guidance Note for Global Fund HIV Proposals

Intervention from the World Health Organization

Eva Charlotte Toth 1*, Jette Tegner 1, Sigurd Lauridsen 2 and Nanna Kappel 1

Questions & Answers. What are the risks associated with consumption drug use?

Integrating hepatitis C treatment in a regional setting The Cairns Experience. DANA 2018 Morag Goodinson

Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario

COMMITMENT TO A TOBACCO ENDGAME IN ONTARIO

A national multidisciplinary healthcare network for treatment of hepatitis C in PWID in Slovenia Prof. Mojca Matičič, MD, PhD

ATLAS on substance use 2017:

Preventing Harm from Substance Use: Harm Reduction. July 6, Dr. Murray Fyfe Medical Health Officer Vancouver Island Health Authority

TRANSITIONING FROM DONOR SUPPORT FOR TB & HIV IN EUROPE

Version for the Silent Procedure 29 April Agenda item January Hepatitis

HIV Prevention, Care and Treatment Services in Prisons of North-Eastern States of India

Hepatitis and HIV Co-Infection: Situation in Ukraine.

Harm reduction among drug users in Spain

Transcription:

ESPACE GAIA, FIRST DCR IN PARIS SINCE OCTOBER 2016 First results and perspectives DISCLOSURE DR Elisabeth AVRIL Presentation : Espace GAIA, first DCR in Paris : first results and perspectives Mundipharma, Giléad Independant consulting on Naloxone/qualitative research on Gaia's hepatitis mobile project in Paris 1

OVERVIEW Thirty years after the opening of the first DCR in Switzerland, France has become the 10 th country to open a drug consumption room, on the 17 of October 2016. The first one has opened in Paris and is handled by the health and social structure Gaïa-Paris, a second one has opened November 7 th in Strasbourg, handled by Ithaque association. Both DCR are located in public hospitals, even though they have a separate entrance and are only administered by the health and social structures in charge. CONTEXT AND HARM REDUCTION IN FRANCE Late 80 s: Launch of Harm Reduction services by civil society organizations (Doctors of the world and AIDES) 2006: Gaia Paris took over Doctor of the World programs in Paris to handle Harm Reduction services: NSP, low threshold OST program, hepatitis c screening mobile unit Since 2007 : Development of an open drug scene in the North East of Paris, in particular around the north station and Lariboisiere hospital (2400 PWUD attended NSP services in Gaia s mobile unit each year since 2008). PWUD inject mostly sulphate morphine and smoke crack cocaine in parking lots, building entrances, public restrooms or on sidewalks. In France, 10% of PWUD are infected by HIV and over 44% have contracted Hepatitis C Precarious and poly addicted users, 60% of them are both injecting (morphine sulphate) and smoking (crack) 2

ON-GOING PROJECT SINCE 2009 Diagnosis of the drug scene made with social partners, harm reduction workers and PWUD 2009: Project drafted by a collective action and submitted to the Ministry of Health and lobbying of deputies and other elected representatives August 2010 : Prime Minister Mr Fillon declares that DCR are neither useful nor desirable 2012: Proposal submitted by Gaïa-Paris and Doctors of the World France to Ministry of Health. Rémi Féraud, mayor of the 10 th district, declared himself in favour of opening a DCR in his district. The government agreed to work on the project in 2013 but the Council of State stopped the process when they declared that the current law was not adapted to protect the establishment of the DCR ADVOCACY ACTIONS Several meetings with local residents to present the project and address worries Harm Reduction sensitization sessions for local police officers Ministry of Health, MILDECA, Paris City hall, local city hall Awareness raising sessions on Harm Reduction/DCR' issues for various stakeholders Coordination with social and health partners Presentations of the project to the staff of Lariboisière Hospital 3

PROJECT IMPLEMENTATION January 2016: Adoption of the Modernization of Public Health Law. Article 43 allows the experimentation for 6 years of drug consumption rooms, in cities that apply for it. Choice of the premises, negotiations with the hospital Construction work in the premises and budget negotiations On going meetings with local residents, police officers and municipal officers Meetings with the Justice Department to establish policing guidelines around the DCR FUNCTIONING OF THE DCR Team composed of GPs, nurses, social workers, security agents and peer workers. The DCR is opened 7/7, from 1:30 PM to 8:30 PM. 1 injection room with 12 booths, 1 inhalation room with 4 booths 4

OPERATING RULES Only for PWID, over 18 years old Free and anonymous Inclusion interview at the 1st visit,assessement, operating rules linked to the signature of a contract 20 minutes for each consumption No restriction on products allowed No limited time in the resting area Services : medical and social consultations, refering to substitution treatments CHARACTERISTICS OF THE PUBLIC Sex ratio 0.1326 Average age : 37.8 years old (21-69) 40% without income 28% with no health coverage 52% homeless 48.33 % have a medical follow up 27% with no social or medical follow up 45% VHC+ (40% with no access to care) 5

CURRENT ACTIVITY SINCE OPENING OCTOBER 2016 669 users included in the program (most of them in very bad conditions) 31 383 visits 21 897 injections Actually about 200 visits/day (65 the day of the opening) 42.6% inject Skenan (morphine sulphate), 43% crack (1/3 inject) 509 medical/nurses consultations for 220 different users 610 social consultations for 188 different users Only 4 emergency so far for OD SCREENING HCV HBV HIV 50 rapid tests for HIV : 3 HIV + 41 rapid tests for HCV : 5 HCV+ 17 DBS : 10 RNA HCV +, 1 HVB+ 26 Fibroscan : 6 F0, 10 F0-F1, 4 F1-F2, 4 F2, 2 F3 30 referrals to the district hospitals, a third of them physically accompanied regarding several issues : detoxification, psychiatry, infectious diseases,... 2 patients are achieving HCV treatment 6

CHALLENGES AND PROSPECTS Difficult to increase the number of visits if no more staff or widening of opening hours and increase of staff Being the only centre opened during week-ends: concentration of users at the DCR (groups of users in front of the DCR) which leads to neighborhood conflicts Crack users more and more numerous and no specific services for them Opening others DCR in Paris region, specially one targeting crack smokers in Paris? Keep on the outstanding collaboration with city hall, state services, police... Main issue is to reorganize the harm reduction strategy (and service offers) in the region, fight the inequality of harm reduction service offers on the territory, inequality of access for to many PWUD 7